Logo

Asterand

MolecularMD, Asterand Bioscience Form Biomarker Alliance

The companies will work together to create an end-to-end workflow for biomarker and drug target validation, and assay development.

Asterand Awarded $6.5M Contract to Provide Tumor Samples, Data to NIH

The company will provide oncology specimens and associated clinical data to the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium.

5AM to Develop Biobanking, Data-Sharing Software for Asterand
Premium

5AM Solutions will develop software that will allow Asterand to electronically link multiple biorepositories and identify, annotate, and distribute biospecimen data internally and with collaborators.

Asterand Lands $5.4M NCI Contract

The contract to supply biospecimens for the Cancer Genome Atlas project could reach a total value of $24 million.

Asterand Subsidiary to Screen Amylin Library

BioSeek will apply its BioMap predictive human disease models to screen Amylin's library.
Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.